Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab

被引:172
作者
Hare, James L. [1 ]
Brown, Joseph K. [1 ]
Leano, Rodel [1 ]
Jenkins, Carly [1 ]
Woodward, Natasha [2 ]
Marwick, Thomas H. [1 ]
机构
[1] Univ Queensland, Brisbane, Qld, Australia
[2] Princess Alexandra Hosp, Dept Med Oncol, Brisbane, Qld 4102, Australia
基金
英国医学研究理事会;
关键词
LEFT-VENTRICULAR FUNCTION; ANTHRACYCLINE TREATMENT; HEART-FAILURE; EXPERIMENTAL VALIDATION; ADJUVANT CHEMOTHERAPY; DOBUTAMINE STRESS; ECHOCARDIOGRAPHY; CARDIOTOXICITY; STRAIN; TRIAL;
D O I
10.1016/j.ahj.2009.05.031
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background Trastuzumab prolongs survival in patients with human epidermal growth factor receptor type 2-positive breast cancer. Sequential left ventricular (LV) ejection fraction (EF) assessment has been mandated to detect myocardial dysfunction because of the risk of heart failure with this treatment. Myocardial deformation imaging is a sensitive means of detecting LV dysfunction, but this technique has not been evaluated in patients treated with trastuzumab. The aim of this study was to investigate whether changes in tissue deformation, assessed by myocardial strain and strain rate (SR), are able to identify LV dysfunction earlier than conventional echocardiographic measures in patients treated with trastuzumab. Methods Sequential echocardiograms (n = 152) were performed in 35 female patients (51 8 years) undergoing trostuzumab therapy for human epidermal growth factor receptor type 2-positive breast cancer. Left ventricular EF was measured by 2- and 3-climensional (2D and 3D) echocardiography, and myocardial deformation was assessed using tissue Doppler imaging and 2D-based (speckle-tracking) strain and SR. Change over time was compared every 3 months between baseline and 12 months. Results There was no overall change in 3D-EF, 2D-EF, myocardial E-velocity, or strain. However, there were significant reductions seen in tissue Doppler imaging SR (P <.05), 2D-SR (P <.001), and 2D radial SR (P<.001). A drop >= 1 SD in 2D longitudinal SR was seen in 18 (51%) patients; 13 (37%) had a similar drop in radial SR. Of the 18 patients with reduced longitudinal SR, 3 had a concurrent reduction in EF >= 10%, and another 2 showed a reduction over 20 months follow-up. Conclusions Myocardial deformation identifies preclinical myocardial dysfunction earlier than conventional measures in women undergoing treatment with trastuzumab for breast cancer. (Am Heart J 2009; 158:294-301.)
引用
收藏
页码:294 / 301
页数:8
相关论文
共 31 条
[1]
Use of peak systolic strain as an index of regional left ventricular function: Comparison with tissue Doppler velocity during dobutamine stress and myocardial ischemia [J].
Armstrong, G ;
Pasquet, A ;
Fukamachi, K ;
Cardon, L ;
Olstad, B ;
Marwick, T .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2000, 13 (08) :731-737
[2]
Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition [J].
Cardinale, Daniela ;
Colombo, Alessandro ;
Sandri, Maria T. ;
Lamantia, Giuseppina ;
Colombo, Nicola ;
Civelli, Maurizio ;
Martinelli, Giovanni ;
Veglia, Fabrizio ;
Fiorentini, Cesare ;
Cipolla, Carlo M. .
CIRCULATION, 2006, 114 (23) :2474-2481
[3]
111Indium-trastuzumab visualises myocardial human epidermal growth factor receptor 2 expression shortly after anthracycline treatment but not during heart failure:: A clue to uncover the mechanisms of trastuzumab-related cardiotoxicity [J].
de Korte, M. A. ;
de Vries, E. G. E. ;
Lub-de Hooge, M. N. ;
Jager, P. L. ;
Gietema, J. A. ;
van der Graaf, W. T. A. ;
Sluiter, W. J. ;
van Veldhuisen, D. J. ;
Suter, T. M. ;
Sleiffer, D. T. ;
Perik, P. J. .
EUROPEAN JOURNAL OF CANCER, 2007, 43 (14) :2046-2051
[4]
Left ventricular ejection fraction and cardiotoxicity: Is our ear really to the ground? [J].
Ewer, Michael S. ;
Lenihan, Daniel J. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (08) :1201-1203
[5]
Reversibility of trastuzumab-related cardiotoxicity: New insights based on clinical course and response to medical treatment [J].
Ewer, MS ;
Vooletich, MT ;
Durand, JB ;
Woods, ML ;
Davis, JR ;
Valero, V ;
Lenihan, DJ .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) :7820-7826
[6]
Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients [J].
Ganamc, Javier ;
Clalis, Piet ;
Uyttebroeck, Anne ;
Renard, Marleen ;
D'hooge, Jan ;
Bijnens, Bart ;
Sutherland, George R. ;
Eyskens, Benedicte ;
Mertens, Luc .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2007, 20 (12) :1351-1358
[7]
Performance of conventional echocardiographic parameters and myocardial measurements in the sequential evaluation of left ventricular function [J].
Hare, James L. ;
Brown, Joseph K. ;
Marwick, Thomas H. .
AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (05) :706-711
[8]
Rapid online quantification of left ventricular volume from real-time three-dimensional echocardiographic data [J].
Jacobs, LD ;
Salgo, IS ;
Goonewardena, S ;
Weinert, L ;
Coon, P ;
Bardo, D ;
Gerard, O ;
Allain, P ;
Zamorano, JL ;
de Isla, LP ;
Mor-Avi, V ;
Lang, RM .
EUROPEAN HEART JOURNAL, 2006, 27 (04) :460-468
[9]
Reproducibility and accuracy of echocardiographic measurements of left ventricular parameters using real-time three-dimensional echocardiography [J].
Jenkins, C ;
Bricknell, K ;
Hanekom, L ;
Marwick, TH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (04) :878-886
[10]
Identification of acutely ischemic myocardium using ultrasonic strain measurements - A clinical study in patients undergoing coronary angioplasty [J].
Kukulski, T ;
Jamal, F ;
Herbots, L ;
D'hooge, J ;
Bijnens, B ;
Hatle, L ;
De Scheerder, I ;
Sutherland, GR .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (05) :810-819